Moleculin Biotech, Inc.

Moleculin Biotech, Inc.https://investorshangout.com/Moleculin-Biotech-Inc-MBRX-91987/en-usSun, 13 Sep 2026 14:02:01 GMTCopyright InvestorsHangout.comwhytestocks: $MBRX News Article - Moleculin Reports Higher AML Complete Remission (CR) Rates and Significant Durahttps://investorshangout.com/post/view?id=6691541https://investorshangout.com/post/view?id=6691541Tue, 07 May 2024 14:46:11 GMTwhytestocks: $MBRX News Article - European Medicines Agency (EMA) Grants Orphan Drug Designation for Moleculin's https://investorshangout.com/post/view?id=6686029https://investorshangout.com/post/view?id=6686029Thu, 18 Apr 2024 18:15:58 GMTwhytestocks: $MBRX News Article - Moleculin Presents Positive Preliminary Efficacy Findings from Phase 1B/2 Clinihttps://investorshangout.com/post/view?id=6641181https://investorshangout.com/post/view?id=6641181Mon, 06 Nov 2023 16:45:46 GMTwhytestocks: $MBRX News Article - Moleculin Announces Publication of Data from Successful European Phase 1 Trial https://investorshangout.com/post/view?id=6595693https://investorshangout.com/post/view?id=6595693Thu, 13 Jul 2023 12:45:46 GMTwhytestocks: $MBRX News Article - Moleculin Announces Presentation of Positive Pharmacokinetics and Tissue-Organ https://investorshangout.com/post/view?id=6562880https://investorshangout.com/post/view?id=6562880Tue, 18 Apr 2023 17:55:47 GMTwhytestocks: $MBRX News Article - Moleculin Announces Acceptance of Abstract to be Presented at the American Assohttps://investorshangout.com/post/view?id=6550849https://investorshangout.com/post/view?id=6550849Tue, 21 Mar 2023 12:55:46 GMTwhytestocks: $MBRX News Article - Moleculin Announces Dosing of First Subject in Italy for Phase 1/2 Trial Evaluahttps://investorshangout.com/post/view?id=6543245https://investorshangout.com/post/view?id=6543245Wed, 01 Mar 2023 19:15:46 GMTwhytestocks: $MBRX News Article - Moleculin Announces Final Topline Data from Successful European Phase 1 Trial Ehttps://investorshangout.com/post/view?id=6536024https://investorshangout.com/post/view?id=6536024Mon, 13 Feb 2023 15:45:48 GMTwhytestocks: $MBRX News Article - Moleculin to Present at the Virtual Investor 2023 Companies to Watch Event https://investorshangout.com/post/view?id=6518892https://investorshangout.com/post/view?id=6518892Thu, 05 Jan 2023 16:00:47 GMTwhytestocks: $MBRX News Article - Moleculin Reports 80% Overall Response Rate in Final Cohort of Phase 1 Single Ahttps://investorshangout.com/post/view?id=6511332https://investorshangout.com/post/view?id=6511332Thu, 15 Dec 2022 15:30:46 GMTwhytestocks: $MBRX News Article - Moleculin Selected to Present at the 2nd Annual Marie Sklodowska-Curie Symposiuhttps://investorshangout.com/post/view?id=6467528https://investorshangout.com/post/view?id=6467528Thu, 08 Sep 2022 16:35:55 GMTwhytestocks: $MBRX News Article - Moleculin to Present at the H.C. Wainwright 24th Annual Global Investment Confehttps://investorshangout.com/post/view?id=6466953https://investorshangout.com/post/view?id=6466953Wed, 07 Sep 2022 17:40:53 GMTznewcar1: MBRX 4% v56,3K c1.47 f28,6M YH1.28 YL=ML1.25https://investorshangout.com/post/view?id=6461600https://investorshangout.com/post/view?id=6461600Fri, 26 Aug 2022 21:47:50 GMTznewcar1: MBRX 1% v19K c1.67 f28,6M H1.70 ML1.26 yet back above mda's LL1.02https://investorshangout.com/post/view?id=6437395https://investorshangout.com/post/view?id=6437395Wed, 13 Jul 2022 17:10:06 GMTwhytestocks: $MBRX News Article - Moleculin to Present at the H.C. Wainwright Global Investment Conference https://investorshangout.com/post/view?id=6406448https://investorshangout.com/post/view?id=6406448Thu, 19 May 2022 15:15:54 GMTwhytestocks: $MBRX News Article - Moleculin to Participate in the 2022 Virtual Growth Conference Presented by Maxhttps://investorshangout.com/post/view?id=6368904https://investorshangout.com/post/view?id=6368904Wed, 23 Mar 2022 20:00:50 GMTznewcar1: MBRX History MBRX 7% v404K c2.33 f28,6M H2.33 30 12/10/2021 5:07:49 PM MBRX 14% v31M c4.25 f28,4Mhttps://investorshangout.com/post/view?id=6299396https://investorshangout.com/post/view?id=6299396Fri, 10 Dec 2021 22:09:44 GMTznewcar1: MBRX 7% v404K c2.33 f28,6M H2.33 30dL@1.91 also LL under $2 again before stock manipulation. Float https://investorshangout.com/post/view?id=6299395https://investorshangout.com/post/view?id=6299395Fri, 10 Dec 2021 22:07:49 GMTwhytestocks: $MBRX News Article - Moleculin Receives FDA Allowance to Begin a Phase 1 Study of WP1122 for the Trehttps://investorshangout.com/post/view?id=6292850https://investorshangout.com/post/view?id=6292850Wed, 01 Dec 2021 20:15:48 GMTwhytestocks: $MBRX News Article - Moleculin to Present at the Oppenheimer Fall Healthcare Life Sciences and MedTehttps://investorshangout.com/post/view?id=6243065https://investorshangout.com/post/view?id=6243065Fri, 17 Sep 2021 19:30:48 GMTwhytestocks: $MBRX News Article - Moleculin Reports First Quarter 2021 Financial Results and Provides Programs Uphttps://investorshangout.com/post/view?id=6133337https://investorshangout.com/post/view?id=6133337Wed, 12 May 2021 19:10:50 GMTznewcar1: MBRX 14% v31M c4.25 f28,4M preMH5 HOD4.77 S4.1 F was 73.1M in 2020-1201 @1.22 Looks like a up pop https://investorshangout.com/post/view?id=6096226https://investorshangout.com/post/view?id=6096226Wed, 31 Mar 2021 04:28:04 GMTwhytestocks: $MBRX News Article - Moleculin Receives FDA Approval of Fast Track Designation for Annamycin in the https://investorshangout.com/post/view?id=6095469https://investorshangout.com/post/view?id=6095469Tue, 30 Mar 2021 14:10:49 GMTchemist823: Looks like a triple waiting to happen. 100% success rate with cancer drug not to mention the potenthttps://investorshangout.com/post/view?id=6051225https://investorshangout.com/post/view?id=6051225Thu, 11 Feb 2021 20:46:49 GMTwhytestocks: $MBRX News Article - Moleculin Announces Full Exercise of Over-Allotment Option https://investorshangout.com/post/view?id=6049673https://investorshangout.com/post/view?id=6049673Wed, 10 Feb 2021 21:35:50 GMTznewcar1: MBRX 35% v53,8M c6.39 f10,4M preMH9.3 S6.77 then ran to HOD8.78 only to fail downhttps://investorshangout.com/post/view?id=6039258https://investorshangout.com/post/view?id=6039258Tue, 02 Feb 2021 21:38:12 GMTwhytestocks: $MBRX News Article - Moleculin Announces 100% Survival Achieved in Osteosarcoma Lung Metastases Animhttps://investorshangout.com/post/view?id=6038097https://investorshangout.com/post/view?id=6038097Tue, 02 Feb 2021 13:00:51 GMTznewcar1: MBRX 26% v50,9M c.990 f62,4M c1.22 f73.1M preMH1.42 HOD1.22 Bear trap S@.95?https://investorshangout.com/post/view?id=5977950https://investorshangout.com/post/view?id=5977950Wed, 02 Dec 2020 03:55:03 GMTwhytestocks: $MBRX News Article - Moleculin Announces FDA Approves 3 Rare Pediatric Disease Designations for WP10https://investorshangout.com/post/view?id=5977205https://investorshangout.com/post/view?id=5977205Tue, 01 Dec 2020 15:05:47 GMTwhytestocks: $MBRX News Article - Moleculin Announces New Data Demonstrating Synergistic Antitumor Activity of Anhttps://investorshangout.com/post/view?id=5967902https://investorshangout.com/post/view?id=5967902Thu, 19 Nov 2020 18:30:48 GMTwhytestocks: $MBRX News Article - Moleculin Biotech, Inc. Reports Financial Results for the Quarter Ended Septembhttps://investorshangout.com/post/view?id=5961738https://investorshangout.com/post/view?id=5961738Fri, 13 Nov 2020 16:45:49 GMTznewcar1: MBRX 20% v45,4M c1.33 f60,4M H1.5 S1.25https://investorshangout.com/post/view?id=5834370https://investorshangout.com/post/view?id=5834370Tue, 21 Jul 2020 21:04:10 GMTznewcar1: MBRX 36% v75,9M c1.07 f60,4M H1.35 S1.03https://investorshangout.com/post/view?id=5828076https://investorshangout.com/post/view?id=5828076Wed, 15 Jul 2020 22:34:23 GMTwhytestocks: $MBRX short squeeze all day https://investorshangout.com/post/view?id=5730989https://investorshangout.com/post/view?id=5730989Fri, 10 Apr 2020 13:55:47 GMTznewcar1: MBRX 125% v168,3M c1.27 f53,2M gap from .52 to 1.6 then Rip to HOD1.97 halted then fell S@1.16?https://investorshangout.com/post/view?id=5729348https://investorshangout.com/post/view?id=5729348Wed, 08 Apr 2020 20:15:54 GMTTonyCorvette: $MBRX Says Active Compound in WP1122 Reduces Coronavirus Replication In Vitro by 100% https://investorshangout.com/post/view?id=5728259https://investorshangout.com/post/view?id=5728259Wed, 08 Apr 2020 11:45:35 GMTznewcar1: MBRX 38% v14,7M c.650 f53,2M preMH@1.62 O~.8 then S@.55https://investorshangout.com/post/view?id=5708889https://investorshangout.com/post/view?id=5708889Thu, 19 Mar 2020 21:44:07 GMTznewcar1: MBRX 30% v15,2M c.5201 f53,2M gap up and fellhttps://investorshangout.com/post/view?id=5706033https://investorshangout.com/post/view?id=5706033Tue, 17 Mar 2020 20:47:40 GMTBooDog: Good news today. Still waiting for earnings. https://investorshangout.com/post/view?id=5705227https://investorshangout.com/post/view?id=5705227Tue, 17 Mar 2020 12:42:11 GMTwhytestocks: $MBRX News Article - Moleculin Announces Successful Completion of US Phase 1 AML Trial of Annamycin https://investorshangout.com/post/view?id=5662871https://investorshangout.com/post/view?id=5662871Mon, 03 Feb 2020 15:50:42 GMTwhytestocks: $MBRX News Article - Moleculin Announces Additional Positive Interim Results from Phase 1/2 Clinicalhttps://investorshangout.com/post/view?id=5609540https://investorshangout.com/post/view?id=5609540Wed, 04 Dec 2019 17:05:43 GMTwhytestocks: $MBRX News Article - Moleculin Announces Positive Trial Data with 100% Safe Delivery of p-STAT3 Inhihttps://investorshangout.com/post/view?id=5596102https://investorshangout.com/post/view?id=5596102Tue, 19 Nov 2019 16:05:43 GMTwhytestocks: $MBRX News Article - Moleculin Announces Beginning of Preclinical Development of New Approach to Panhttps://investorshangout.com/post/view?id=5591245https://investorshangout.com/post/view?id=5591245Wed, 13 Nov 2019 18:40:44 GMTjonny_red32: 4 Penny Stocks To Buy For Under $1.70 Right Now $ACRS $BNGO $MBRX $TTNP https://www.transparehttps://investorshangout.com/post/view?id=5571939https://investorshangout.com/post/view?id=5571939Wed, 23 Oct 2019 11:41:50 GMTwhytestocks: $MBRX News Article - Investors are Unsure How to React (Brief Analysis)- Moleculin Biotech, Inc. (NAhttps://investorshangout.com/post/view?id=5517403https://investorshangout.com/post/view?id=5517403Wed, 21 Aug 2019 18:56:38 GMTwhytestocks: $MBRX News Article - Exceptional Stock in Review- Moleculin Biotech, Inc. (NASDAQ:MBRX) https://investorshangout.com/post/view?id=5511715https://investorshangout.com/post/view?id=5511715Thu, 15 Aug 2019 17:20:40 GMTwhytestocks: $MBRX News Article - Bright Trending Stock- Moleculin Biotech, Inc. (NASDAQ:MBRX) https://investorshangout.com/post/view?id=5508304https://investorshangout.com/post/view?id=5508304Mon, 12 Aug 2019 19:45:40 GMTwhytestocks: $MBRX News Article - Moleculin Files for New Patents for Annamycin After Receiving FDA Approval of Fhttps://investorshangout.com/post/view?id=5480159https://investorshangout.com/post/view?id=5480159Wed, 10 Jul 2019 14:27:04 GMTBooDog: Just started building my position at 1.32. https://investorshangout.com/post/view?id=5431792https://investorshangout.com/post/view?id=5431792Wed, 08 May 2019 14:00:44 GMTwhytestocks: $MBRX News Article - Moleculin Announces Additional Positive Interim Results in First Cohort of Phashttps://investorshangout.com/post/view?id=5430791https://investorshangout.com/post/view?id=5430791Tue, 07 May 2019 14:25:40 GMT